Bram Verstockt
University Hospitals Leuven
Appearances
- DateMay 7, 2023The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
Presenter
Speakers
University Hospitals LeuvenIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai - DateMay 8, 2023BACKGROUND: Mesenteric fat is increasingly believed to exert an important influence on intestinal inflammation. A hallmark of severe Crohn's disease (CD) is the accumulation of mesenteric fat around the inflamed intestine, typically in the terminal ileum…
Presenter
Speakers
Katholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenUniversity Hospitals Leuven - DateMay 8, 2023SOCIETY: AGA
Moderators
Yale School of MedicineUniversity Hospitals Leuven - DateMay 18, 2024
Presenter
University Hospitals Leuven - DateMay 18, 2024
Presenters
Katholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenNorthwestern University Feinberg School of MedicineUniversity of California San DiegoUniversity Hospitals Leuven - DateMay 19, 2024Genome-wide association studies revealed single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD) in coding regions of autophagy-related genes, such as _ATG16L1_ and _NOD2_…
Speakers
University Hospitals LeuvenPresenter
- DateMay 19, 2024Vedolizumab (VDZ) is a monoclonal antibody that targets the gut-homing receptor α4β7. Despite its widespread use as a frontline therapy for ulcerative colitis (UC) and Crohn’s disease, its mode of action (MOA) remains unclear…
Presenter
Speakers
University Hospitals LeuvenIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai - DateMay 19, 2024Background: Although the precise role of eosinophils in IBD is debated, elevated eosinophils may influence response to therapy and clinical outcomes1. Thus, therapeutic agents which affect both neutrophil and eosinophil recruitment may provide more robust clinical improvement in patients with UC…
Presenter
Katholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenSpeakers
Icahn School of Medicine, Mount SinaiUniversity Hospitals Leuven - DateMay 18, 2024(WITHDRAWN) SINGLE CELL ANALYSIS OF GUT BIOPSY TISSUE REVEALS CELL TYPE- AND INFLAMMATION-SPECIFIC EXPRESSION QUANTATIVE TRAIT LOCI IN CROHN'S DISEASE
Moderators
Icahn School of Medicine at Mount SinaiUniversity Hospitals Leuven - DateMay 21, 2024Microscopic colitis (MC) is a chronic inflammatory condition of the colon, resulting in an impaired quality of life due to debilitating watery diarrhea. First-line therapy consists of budesonide, though a subset of patients is refractory or becomes budesonide- dependent…
Presenter
University Hospitals LeuvenSpeakers
- DateMay 20, 2024INTRO/BACKGROUND Rigorous donor preselection on microbiota level, strict anaerobic processing, and repeated FMT administration were hypothesized to improve FMT outcomes for induction of remission in UC in the RESTORE-UC trial, for which we here report on the clinical results and observed microbial…
Presenter
Speakers
University Hospitals LeuvenKatholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven - DateMay 19, 2024BACKGROUND: Neutrophil extracellular traps (NETs) consist of DNA filaments and cytoplasmic protein granules, extruded by neutrophils after PAD4-dependent activation…
Presenter
Speakers
University Hospitals LeuvenKatholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven - DateMay 19, 2024Assessment of mucosal healing as a key denominator in the treat-to-target strategy for managing ulcerative colitis remains challenging. To address this, objective evaluation of histological disease activity holds promise…
Presenter
Speakers
University Hospitals LeuvenKatholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenUniversity Hospital Leuven - DateMay 18, 2024SOCIETY: AGA With the expansion of IBD treatment options, there is increasingly the need for predictive models to determine which treatments work best for which patients with IBD…
Moderators
Cincinnati Children’s Hospital Medical CenterCedars-Sinai Medical CenterSpeakers
Katholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenNorthwestern University Feinberg School of MedicineUniversity Hospitals Leuven - DateMay 3, 2025This session will discuss novel findings in IBD genetics in different populations, including large scale exome sequencing and the effect of ancestry on the genetic make up in IBD…
Moderators
University Hospitals LeuvenCedars-Sinai Medical Center